Pharma Glass USP <660>

Pharmaceutical Glass Containers (USP <660> / EP 3.2.1) Water Resistance Guide

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Analyzing glass container classifications (Type I, II, III), glass grains water resistance assay criteria, and delamination risk assessments.

Key answer

Pharmaceutical glass is classified into Type I borosilicate glass (highly resistant, ideal for injectables), Type II treated soda-lime glass (surface de-alkalized using acid gas treatment), and Type III soda-lime glass (moderate resistance, limited to non-aqueous or dry oral drugs). Tests (USP <660>) include the Glass Grains Test and surface water resistance assays, measuring acidic titration volumes.

Failure Mechanism of Glass Delamination in Vials

Glass delamination represents a failure where tiny flakes detach from the vial’s inner surface under chemical attack by liquid formulations, posing patient hazards.

  • High-risk factors: high pH formulas (pH > 8) and formulations with citrate/tartrate chelators stored long-term
  • Manufacturing defects: high temperatures during glass blowing causing trace boron/sodium volatilization, yielding fragile layers
  • Delamination assessment: using SEM or optical interferometers to evaluate micro-pits and surface exfoliation grades post-stress

FAQ

How do you distinguish Type I from Type II glass?+

You must apply the Glass Grains Test. Type I borosilicate glass has chemical resistance throughout its structure. Type II is soda-lime glass chemically treated only on its inner surface. If both are crushed into grains, the de-alkalized layer of Type II is destroyed, and it will fail Type I grains limits.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.